(Q77752526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

The diagnosis and management of neurofibromatosis 2 in childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

neurofibromatosis type II

8 December 2019

main subject

1 reference

M MacCollin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

V F Mautner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

Seminars in pediatric neurology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

243-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

Multiple primary intracranial tumors in von Recklinghausen's neurofibromatosis.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Familial central nervous system neoplasia. Case report of a family with von Recklinghausen's neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Primary cutaneous meningioma associated with von Recklinghausen's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Neurofibromatosis 2 in the pediatric age group.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

The neuroimaging and clinical spectrum of neurofibromatosis 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Visual impairment in patients with neurofibromatosis 2

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Ocular abnormalities in neurofibromatosis 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Acoustic neuroma and the eye

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Neurofibromatosis 2: loss of merlin's protective spell

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Familial meningioma is not allelic to neurofibromatosis 2

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Clonality of multiple meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Vestibular schwannoma (acoustic neuroma). Consensus development conference

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Preservation of hearing and facial nerve function in resection of acoustic neuroma

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Comprehensive management of bilateral acoustic neuromas. Current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

The multichannel auditory brain stem implant: performance in twenty patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980003-X

7 January 2021

10.1016/S1071-9091(98)80003-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9874852%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference